Navigation Links
Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
Date:8/17/2010

news/earnings-list">Earnings Click to view news release full screen  

Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million

 

XIANYANG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (Nasdaq: BSPM) ("Biostar" or "the Company"), a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing Capsules"), and a variety of pharmaceutical products, today announced financial results of the second quarter ended June 30, 2010.

-- Q2 2010 revenue increased 46.4% to $19.4 million -- Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 -- Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income between $18.0 to $20.0 million SUMMARY FINANCIALS Second Quarter 2010 Results (unaudited) Q2 2010 Q2 2009 CHANGE Net Sales $19.4 million $13.2 million +46.4% Gross Profit $14.4 million $9.7 million +47.8% GAAP Net Income $5.6 million $3.9 million +44.7% Adjusted Non-GAAP Net Income* $5.8 million $3.9 million +50.9% GAAP EPS (Diluted) $0.20 $0.16 +25.0% Adjusted Non-GAAP EPS $0.21 $0.16 +31.2% (Diluted)* * Excluding non-cash stock-based compensation charge of $0.2 million for Q2 2010. For more information about the non-GAAP financial measures contained in this press release, please see "About Non-GAAP Financial Measures" below. Six Months 2010 Results (unaudited) 6-Month 2010 6-Month 2009 CHANGE Net Sales $31.8 million $20.7 million +53.5% Gross Profit $23.9 million $14.5 million +64.6% GAAP Net Income $7.8 million $5.7 million +38.0% Adjusted Non-GAAP Net Income
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
2. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
3. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
4. Biostar Pharmaceuticals Approved for Listing on NASDAQ Global Market
5. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
11. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Quebec , June 18, 2013 Valeant ... TSX: VRX) (the "Company") announced today that VPII Escrow ... the Company, has launched its offer of approximately $3.2 ... "Notes").  The Notes will be due in 2021 and ... The Company intends to use the net proceeds ...
(Date:6/18/2013)... N.J. , June 18, 2013  Actavis, Inc. (NYSE: ... Actavis") has filed with the U.S. Securities and Exchange Commission ... Actavis, proposed acquisition of Warner Chilcott plc (NASDAQ: ... of Actavis and Warner Chilcott (the "Form S-4"). ... and Warner Chilcott have entered into a definitive ...
(Date:6/18/2013)... 18, 2013  Millennium HealthCare Inc. (OTC Pink: ... an exclusive 25-year Supply and Distribution agreement for ... ("EWC") for its Distance Monitored Physical Therapy Program ... therapy program is a critical element in reducing ... Chris Amandola , president, Millennium HealthCare Inc.  ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
(Date:6/19/2013)... Children had half as many emergency department ... hours on five or more days a week, according ... Mott Children,s Hospital and Johns Hopkins University. , The ... The Journal of Pediatrics and will be presented ... are an important step in understanding where primary care ...
(Date:6/19/2013)... Casual, no-strings sexual encounters are increasingly common on ... than others to "hook up"? A new study ... Behavioral and Preventive Medicine, published online by the ... are certain factors and behaviors associated with sexual ... "Given the potential for negative emotional and physical ...
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... at Louisiana State University have developed a method for ... relies on understanding the genetic interaction between single nucleotide ... prostate cancer,s aggressiveness to avoid unnecessary radical treatment. ... PLOS ONE in April. , According to ... all cancers and 9 percent of cancer deaths. It ...
(Date:6/19/2013)... June 19, 2013 Alternatives, a revolutionary ... patients to quit using drugs while allowing them to ... the founders of Alternatives, believe that abstinence-only approaches force ... enter treatment and that this approach hurts instead of ... in the United States need treatment for addiction but ...
Breaking Medicine News(10 mins):Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3
... Angeles, study the diet patterns in 52 normal weight people ... normal people generally ate more fruits and fibres than their ... the Journal of the American Dietetic Association stated that the ... and fruit intake, plays a role in the development of ...
... were related to drinking have more than doubled in Britain in ... yesterday by the Office for National Statistics (ONS) revealed has revealed ... in 2004. The statistics also showed that the alcohol related deaths ... is increasing in recent years. ,It was explained that ...
... in North Carolina and Virginia found evidence of pesticide ... call for pesticide safety training for workers’ spouses. ... Wake Forest University School of Medicine report that urine ... exposure than had been found in similar studies elsewhere. ...
... smoking in enclosed places and has put the draft regulation ... said that the government wanted to know about the people's ... and also said that it would be nice if the ... the Tories say that the plan would be expensive and ...
... be mandatory on all tobacco products soon failing which ... ,Other health warnings that could appear on ... pictorial representation of ill-effects of tobacco use and a ... headed by Anbumani Ramadoss, who has been a staunch ...
... has signed a memorandum of understanding (MOU) with the Clinton ... of affordable//, high- quality drugs as well as diagnostics for ... at the Presidential Villa with Nigerian President Olusegun Obasanjo and ... to Nigeria, as witnesses. ,According to the agreement, ...
Cached Medicine News:Health News:Better Weight Management Can be Achieved By Increased Intake Of Fibre & Fruits 2Health News:Research Documents Children’s Exposure to Pesticide 2
... Size: 3.0 x 7.5 x 80 ... Sponge II line designed by Harvey ... is a closed cell sponge which ... soft with rounded edges to minimize ...
... Size: 4.0 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... cell sponge which is non-toxic and ... edges to minimize scleral intrusion. These ...
For use with E5381 700 Circling Band (240 style). 1.65 mm diameter, 30.0 mm long....
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Medicine Products: